Stryker Corp. regulatory expert Ommeed Shahrokh explains the device giant’s decision-making process around product recalls and describes what’s included in recall letters to customers.
A Stryker Corp. regulatory expert says the medical device giant considers “three essential components” and leans on risk management principles when deciding whether to launch a product recall.
Ommeed Shahrokh, director of regulatory, compliance and QMS integration for Stryker, manages recalls for the company’s joint replacement division. He...
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”
The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.
